Cong He Selected Research

Liver Neoplasms (Liver Cancer)

1/2022	Microvesicles: the functional mediators in sorafenib resistance.
4/2021	Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cong He Research Topics

Disease

27	Neoplasms (Cancer) 03/2024 - 04/2012
19	Infections 08/2023 - 11/2012
9	Carcinogenesis 01/2023 - 01/2018
8	Inflammation (Inflammations) 04/2024 - 01/2018
8	Pancreatitis 12/2023 - 01/2019
6	Dysbiosis 07/2023 - 01/2018
4	Acute Necrotizing Pancreatitis 01/2023 - 01/2019
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2018
4	Insulin Resistance 03/2021 - 04/2014
3	COVID-19 01/2023 - 01/2020
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 05/2017
2	Necrosis 04/2024 - 06/2020
2	Papillary Thyroid Cancer 03/2024 - 01/2023
2	Thyroid Neoplasms (Thyroid Cancer) 03/2024 - 01/2023
2	Laryngopharyngeal Reflux 01/2024 - 06/2022
2	Diabetes Mellitus 11/2023 - 04/2014
2	Hyperglycemia 11/2023 - 03/2021
2	Hepatitis B 01/2023 - 08/2017
2	Septic Shock (Toxic Shock Syndrome) 12/2022 - 04/2020
2	Metaplasia 01/2022 - 12/2021
2	Gastritis 01/2022 - 08/2019
2	Liver Neoplasms (Liver Cancer) 01/2022 - 04/2021
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2020
2	Body Weight (Weight, Body) 03/2021 - 01/2020
2	Sepsis (Septicemia) 01/2021 - 09/2020
2	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 01/2017
2	Vitamin A Deficiency 01/2020 - 11/2012
2	Atherosclerotic Plaque (Atheroma) 11/2017 - 01/2014
2	Chronic Hepatitis B 08/2017 - 07/2015
1	Pathologic Processes 04/2024
1	Edema (Dropsy) 04/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024
1	Anaplastic Thyroid Carcinoma 03/2024
1	Gastroesophageal Reflux (GERD) 01/2024
1	Acute Lung Injury 12/2023
1	Chronic Disease (Chronic Diseases) 11/2023
1	Shock 01/2023
1	Hemochromatosis (Bronze Diabetes) 01/2023
1	Dengue (Dengue Fever) 01/2023

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2017
6	Insulin (Novolin)FDA Link 11/2023 - 04/2014
5	Sorafenib (BAY 43-9006)FDA Link 05/2023 - 01/2020
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 04/2014
4	Therapeutic UsesIBA 03/2024 - 05/2020
4	CytokinesIBA 12/2023 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 04/2019
4	LipidsIBA 11/2020 - 04/2014
3	RNA (Ribonucleic Acid)IBA 03/2024 - 10/2018
3	Amoxicillin (Wymox)FDA LinkGeneric 01/2023 - 01/2022
3	CateninsIBA 01/2023 - 01/2018
3	16S Ribosomal RNAIBA 01/2022 - 01/2018
3	Chimeric Antigen ReceptorsIBA 09/2021 - 07/2020
3	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 04/2014
2	CeruletideIBA 04/2024 - 01/2019
2	CholesterolIBA 03/2024 - 11/2015
2	Pepsin A (Pepsin)IBA 01/2024 - 06/2022
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2023 - 04/2020
2	BismuthIBA 01/2023 - 08/2019
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 07/2015
2	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 10/2022 - 01/2022
2	AcidsIBA 06/2022 - 01/2022
2	shikoninIBA 01/2022 - 05/2021
2	Small Interfering RNA (siRNA)IBA 10/2021 - 01/2021
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 05/2017
2	Vitamin A (Retinol)FDA LinkGeneric 01/2021 - 11/2012
2	LigandsIBA 07/2020 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 11/2015
1	NLR ProteinsIBA 04/2024
1	CD19-specific chimeric antigen receptorIBA 03/2024
1	Small Cytoplasmic RNAIBA 03/2024
1	famitinibIBA 03/2024
1	Metal-Organic FrameworksIBA 03/2024
1	Anti-Infective Agents (Microbicides)IBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024
1	liyanIBA 01/2024
1	InterleukinsIBA 12/2023
1	Da-Cheng-QiIBA 12/2023
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2023
1	ethyleneIBA 08/2023
1	8- (4- carboxymethyloxy)phenyl- 1,3- dipropylxanthineIBA 08/2023
1	Lactulose (Duphalac)FDA LinkGeneric 07/2023
1	Volatile Fatty AcidsIBA 07/2023
1	Transcription Factors (Transcription Factor)IBA 05/2023
1	IQ motif containing GTPase activating protein 1IBA 05/2023
1	Pantoprazole (Protonix)FDA LinkGeneric 01/2023
1	GastrinsIBA 01/2023
1	InterferonsIBA 01/2023
1	CX 5461IBA 01/2023
1	prolinedithiocarbamate (PDTC)IBA 01/2023
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2023

Therapy/Procedure

18	Therapeutics 03/2024 - 04/2012
5	Immunotherapy 03/2024 - 07/2020
2	Fecal Microbiota Transplantation 01/2021 - 09/2019
2	Punctures 01/2021 - 09/2020
2	Ligation 01/2021 - 09/2020
2	Artificial Respiration (Mechanical Ventilation) 07/2020 - 05/2020
1	Length of Stay 01/2023